Alzheimer’s discovery reveals brain cleaning gone wrong (IMAGE)
Caption
“These findings break new ground in our understanding of how this genetic risk factor contributes to Alzheimer’s disease,” said researcher John Lukens, PhD, director of the University of Virginia's Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases. “Our work further suggests that defective CASS4 [gene] activity may serve as an early onset biomarker to detect Alzheimer’s and that therapeutic strategies which boost its function may offer a much-needed approach to treat this devastating brain disease.”
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the Alzheimer's discovery. All other uses require express written permission from UVA Health.
License
Original content